Treatment of hyperphosphataemia in patients with end stage renal disease
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
V VARIOUS
V03 ALL OTHER THERAPEUTIC PRODUCTS
V03A ALL OTHER THERAPEUTIC PRODUCTS
V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
V03AE03 Lanthanum carbonate
D04667 Lanthanum carbonate (USAN) <JP/US>
USP drug classification [BR:br08302]
Electrolytes/Minerals/Metals/Vitamins
Phosphate Binders
Lanthanum
D04667 Lanthanum carbonate (USAN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
219 Miscellaneous
2190 Miscellaneous
D04667 Lanthanum carbonate (USAN); Lanthanum carbonate hydrate (JAN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D04667
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D04667
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D04667